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Abstract
Background: Recent observational studies have shown that patients with chronic kidney disease 
(CKD) have higher risk of atrial fibrillation (AF) recurrence and, therefore, the value of catheter 
ablation therapy in patients with CKD has been doubted. The purpose of this meta-analysis was 
to systematically analyze the effect of CKD on recurrence of AF following catheter ablation.
Methods: PubMed and Cochrane clinical trials databases were searched until August 2012. 
Of the 1966 initially identified studies, 4 observational studies with 1379 patients were analyzed.
Results: The meta-analysis of these studies showed that CKD was associated with higher AF 
recurrence rate following single catheter ablation (HR = 1.96, 95% CI 1.35–2.85, p = 0.0004) 
while there were significant differences between individual trials (p = 0.07 and I2 = 58%). 
Sensitivity analysis suggested that this outcome was stable. A subgroup analysis showed that 
CKD has higher recurrent risk in patients with 100% paroxysmal AF (HR = 2.45, 95% CI 
1.28–4.70, p = 0.007) than in patients with non 100% paroxysmal AF (HR = 1.65, 95% CI 
1.15–2.36, p = 0.006).
Conclusions: CKD was associated with higher AF recurrence rate following single catheter 
ablation. In addition, patients with 100% paroxysmal AF have higher risk than patients with 
non 100% paroxysmal AF that merits special consideration when evaluating patients for 
catheter-based AF ablation. Given that the CKD prevalence is rapidly increasing, there is an 
imperative need for better risk stratification of catheter ablation candidates. (Cardiol J 2014; 
21, 1: 89–95)
Key words: chronic kidney disease, hemodialysis, atrial fibrillation,  
catheter ablation
Introduction
Renal function is known to be a causal reason 
of cardiovascular mortality and an independent 
predictor of a major complication of contemporary 
catheter ablation [1, 2]. Arrhythmia issues arise 
frequently in the renal disease population, span-
ning the spectrum from benign ectopy to sustained 
arrhythmias [3]. The presence of chronic kidney 
disease (CKD) increased the risk of atrial fibrilla-
tion (AF) recurrence after electrical cardioversion 
by catheter ablation [4, 5]. Multifactorial physio-
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logic factors, due to CKD, may take part in higher 
prevalence of recurrent AF in patients with CKD 
than in those without it [4]. In this comprehensive 
meta-analysis and systematic review we sought 
to examine the current evidence and investigate 
whether the presence of CKD increases the risk of 
AF recurrence following single catheter ablation.
Methods
We performed this analysis according to the 
guidelines of the Meta-analysis of Observational 
Studies in Epidemiology Group (MOOSE) [6].
Inclusion criteria
We included prospective or retrospective 
observational studies with a primary objective 
to analyze the association between CKD and re-
currence of AF after catheter ablation. Titles and 
abstracts of all articles were evaluated and rejected 
following the inclusion criteria: 1) human subjects 
with AF; 2) renal function evaluated; 3) retro-
spective/prospective cohort studies; 4) baseline 
data available; 5) follow-up interval longer than 1 
year; 6) AF recurrence following a single catheter 
ablation for CKD and non-CKD patients mentio-
ned; 7) single catheter ablation for AF performed; 
8) enough sample size (n > 100) of patients with 
and without CKD.
Search strategies
We carefully searched on-line database of 
PubMed until August 2012, and the Cochrane Con-
trolled Trials Register Databases until August 2012 
to identify relevant studies. We used the following 
key words: “atrial fibrillation”, “chronic kidney 
disease”, “catheter ablation”, “renal failure”, “renal 
function”, “renal insufficiency”, “end-stage renal 
disease” and “dialysis”. Titles and abstracts, as well 
as the reference lists of all the identified reports, 
were examined independently by 2 reviewers (ML 
and TL) in order to include potentially relevant 
studies. The 2 reviewers agreed on the inclusion/ 
/exclusion status in 90% of the reviewed studies. 
Disagreements were resolved by discussion or 
consensus of a third reviewer (GL). There was no 
language restriction when we included the stu-
dies. Additionally, a manual search was conducted 
using review articles on this topic, bibliographies 
of original papers, and abstracts of the scientific 
sessions of the American College of Cardiology, 
the American Heart Association, the European 
Society of Cardiology, and Heart Rhythm Society 
during the past 3 years.
Quality assessment
To limit heterogeneity secondary to differen-
ces between study designs, the quality of each 
study was evaluated according to the guidelines 
developed by the United States Preventive Task 
Force [7] and the Evidence-Based Medicine Wor-
king Group [8]. A point score system was applied 
based on the quality of the study. The following 
characteristics were assessed: 1) clear description 
of inclusion and exclusion criteria; 2) study sample 
representative for mentioned population; 3) clear 
description of sample selection; 4) full specification 
of clinical and demographic variables; 5) follow-up 
interval longer than 1 year; 6) no loss of follow-
-up; 7) clear definition of CKD; 8) clear definition 
of outcomes and outcome assessment; 9) tempo-
rality (assessment of CKD done before catheter 
ablation); 10) adjustment of possible confounders 
in multivariate analysis. If a study did not clearly 
mention one of these key points, we considered 
that it had not been performed. Therefore, the 
possibility of underestimation of the reported 
characteristics may be present.
Data extraction
Two blind investigators (ML and TL) indepen-
dently performed data extraction using a standard 
data extraction form to determine eligibility for 
inclusion. The following information collected 
was tabulated: 1) publication details: first author’s 
last name, publication year; 2) characteristics of 
included studies: study population, cohort design, 
method of AF detection, ablation strategy, defini-
tion of CKD, follow-up period, blanking period and 
risk estimate; 3) baseline data of the studied popu-
lation: sample size, age, gender, body mass index, 
paroxysmal atrial fibrillation (PAF, %), duration of 
AF, number of patients with CKD, etc.
Statistical analysis
The magnitude of association between CKD 
and recurrence of AF following single catheter 
ablation was measured by adjusted hazard ratio 
(HR) or relative risk (RR) with 95% confidence 
intervals (CI). One study [9] gave a value of HR by 
univariate analysis. Two studies [4, 10] employed 
Cox proportional hazard models to draw a value of 
adjusted HRs. However, in one study [5] neither 
a value of HR nor adjusted HR is available. For the 
present analyses, we assumed RR to be a valid 
approximation of HR. Log HR was transformed 
by taking their logarithms and standard errors 
were calculated from Log HR and corresponding 
95% CI. We used the inverse variance method to 
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weigh  studies for the combined overall statistic. 
Heterogeneity was examined using the standard 
c2 test of heterogeneity. An I2 > 50% indicates at 
least moderate statistical heterogeneity [11]. If the 
c2-test for heterogeneity was significant, a pooled 
effect was calculated with a random-effects model 
which was used to take into account within-study 
and between-study variance, otherwise, with a 
fixed-effects model. Sensitivity analysis was done 
by leaving out studies and checking the consi-
stency of the overall effect estimate. Statistical 
significance for treatment effect was defined at 
p values < 0.05. We also performed subgroup ana-
lysis on two subsets of studies which all subjects 
had PAF or not. Publication bias was evaluated 
using funnel plot although relative small number 
of studies enrolled. All analyses were performed 
using Review Manager Version 5.1 (Revman; The 
Cochrane Collaboration, Oxford, UK).
Results
A total of 1966 records were identified by 
the primary literature search. We identified 811 du- 
plicate articles which were discarded. How ever, 
after screening the titles and abstracts, 1155 stu- 
dies were excluded because they were either la-
boratory studies, review articles,or irrelevant to the 
current analysis. Of the 10 reports selected for 
detailed evaluation, 6 studies did not meet the in- 
clu sion criteria and were excluded [1, 2, 12–15]. 
Among them, 4 [2, 12–14] did not mention AF 
recurrence after a single catheter ablation for 
CKD and non-CKD patients, 1 [1] baseline data 
unavailable and 1 [15] did not have enough sam-
ple size of patients with and without CKD. Con-
sequently, 4 [4, 5, 9, 10] observational studies 
were finally included in our meta-analysis (Fig. 1). 
All of the 4 studies used retrospective data. There 
were overall 1379 patients involved in our analysis. 
The follow-up period ranged from 12 and 56 months. 
The characteristics of included studies are depicted 
in Table 1. The baseline data of the patients in each 
study are presented in Table 2. The definitions of 
CKD varied: 4 studies used reduced estimated 
glomerular filtration rate (eGFR) assessed by the 
MDRD formula [16] or the Cockcroft-Gault formula.
The meta-analysis of these studies demon-
strated that CKD was associated with higher re-
currence rate of AF after catheter ablation (HR = 
= 1.96, 95% CI 1.35–2.85, p = 0.0004) (Fig. 2). The 
heterogeneity test showed there were significant 
differences between individual studies (p = 0.07, 
I2 = 58%). Sensitivity analysis was performed to 
find the origin of heterogeneity. After removing the 
study by Chao et al. [5], whose blanking period was 
2 months, there was no significant heterogeneity 
across the studies (p = 0.42, I2 = 0%). However, the 
overall outcome remained the same (HR = 1.61, 
95% CI 1.26–2.05, p = 0.0001). Excluding the study 
by Berkowitsch et al. [10], whose definition of CKD 
is eGFR < 68 mL/min/1.73 m2, also reduced the he-
terogeneity (p = 0.29, I2 = 20%) without changing 
the overall effect (HR = 2.32, 95% CI 1.61–3.35, 
p < 0.00001). We also performed a subgroup ana-
lysis (Fig. 3) which demonstrated that CKD was 
associated with higher recurrent risk in patients 
with 100% PAF (HR = 2.45, 95% CI 1.28–4.70, 
Figure 1. Flow diagram of study selection process; AF — atrial fibrillation; CKD — chronic kidney disease.
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p = 0.007) [5, 9] than in patients with non 100% 
PAF (HR = 1.65, 95% CI 1.15–2.36, p = 0.006) 
[4, 10]. The funnel plot (Fig. 4) suggested that there 
was no publication bias, although the small number 
of studies made it difficult to interpret.
Discussion
In this comprehensive meta-analysis, we 
showed that patients with CKD were associated 
with increased rate of AF recurrence following 
single catheter ablation. The prevalence of AF is 
much greater among persons with end-stage renal 
disease than among the general population [17]. 
Recent studies indicated that CKD and a decre-
ased GFR was associated with high recurrence 
rate of catheter ablation in patients with PAF 
[4, 5, 9]. Another study clearly demonstrated that 
the outcome after 1st catheter ablation of AF is 
poor in patients with impaired renal function [10]. 
A significant elevation in AF risk was observed at 
a threshold eGFR of < 60 mL/min/1.73 m2 [18].
Cardiorenal syndrome leads to higher numbers 
of individuals suffering from bidirectional disorder 
[19]. Regardless of severity, CKD is associated with 
an increased prevalence of AF among US adults 
[20]. In a large population-based study, reduced 
kidney function was strongly associated with the 
incidence of AF independently of other risk fac-
tors [21]. Elimination of AF by catheter ablation 
improved kidney function in patients with mild to 
moderate kidney dysfunction [1].
Several pathophysiologic mechanisms have 
been proposed as being responsible for the associa-
tion between CKD and AF. CKD may cause cardiac 
and atrial structural changes which are responsible 
for the increased incidence of cardiac arrhythmias 
[22]. Metabolic abnormalities such as metabolic 
acidosis, dyskaliemia and dyscalcemia can also 
lead to an increased risk of AF [23]. Accumulated 
evidence suggests oxidative stress may play an 
important role in the pathogenesis and perpetu-
ation of AF [24, 25]. Indices of oxidative stress 
are increased with severity of kidney disease and 
correlates significantly with level of renal function 
[26]. For example, in the left atrium, expressions 
of nicotinamide adenine dinucleotide phosphate 
oxidase and malondialdehyde were increased by 
CKD [27].
Limitations of the study
Meta-analyses of observational studies pre-
sent particular challenges because of inherent 
biases and differences in study designs. This meta-
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-analysis is limited because number of included 
studies is low and sample size is small. The results 
of all 4 studies are positive which may indicate 
a significant publication bias. Moreover, the present 
study was a meta-analysis of observational studies 
only. Because of the nature of the hypothesis, it 
is only possible for studies to be designed in this 
manner. Therefore, our analysis has demonstrated 
an association but not causality and is hypothesis 
generating. We used eGFR < 60 mL/min/1.73 m2 
as a diagnostic standard for CKD, but this is not the 
reference standard for diagnosing CKD and has its 
limitations. However, this did not alter the overall 
result. The study by Tokuda et al. [9] only gave 
univariate HR value and we manually calculated 
HR value of the study by Chao et al. [5]. Similar 
to other meta-analyses, because of the lack of data 
from the included studies, we were unable to adjust 
risk factors by multivariate regression. The study 
by Berkowitsch et al. [10] enrolled the largest 
Table 2. Baseline data of patients included in the meta-analysis.
Investigator
Berkowitsch Chao Naruse Tokuda
Patient number 702 232 221 224
Mean age 58 53.4 ± 11.6 59 ± 11 55.3 ± 11.7
Gender (male/female) 478/224 168/64 179/42 187/37
Body mass index 26.96 24.9 24.5 ± 3.3 24.2 ± 5.5
Paroxysmal AF 59.26% 100% 57.47% 100%
Duration of AF [years] 5 4.1 ± 3.9 5.8 ± 5.4 (paroxysmal) 4.4 ± 3.9
2.8 ± 4.5 (persistent)
LVEF [%] 60 59.9 64.7 ± 10 67.1 ± 6.6
LA diameter [mm] NA 38.2 NA 38.0 ± 5.3
Structural heart disease 62 (8.83%) 36 (15.5%) 22 (10%) 34 (15%)
Hypertension 487 (69.37%) 82 (35.3%) 128 (58%) 56 (25%)
Diabetes mellitus 46 (6.55%) 15 (6.5%) 19 (8.6%) NA
Dyslipidemia NA 38 (16.4%) 111 (50%) NA
ACEI/ARB NA 48 (20.7%) 117 (53%) 38 (17%)
Class I antiarrhythmic drug NA NA 173 (78%) Ia: 108 (48.1%)
Ic: 160 (71.3%)
Class III antiarrhythmic drug NA NA 10 (47%) 69 (30.6%)
No. of antiarrhythmic drug NA NA 3.2 ± 1.2 1.8 ± 0.8
Statins NA 8 (3.4%) 69 (31%) NA
eGFR [mL/min/1.73 m2] 88.1 79.4 71.7 ± 19.8 77.3 ± 17.1
ACEI — angiotensin converting enzyme inhibitor; ARB — angiotensin receptor blocker; AF — atrial fibrillation; eGFR — estimated glomerular 
filtration rate; LA — left atrium; LVEF — left ventricular ejection fraction; NA — not applicable
Figure 2. Comparison of atrial fibrillation recurrence following single catheter ablation between patients with and 
without chronic kidney disease (CKD); CI — confidence interval; SE — standard error.
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Figure 4. Funnel plot of the meta-analysis; SE — stan-
dard error.
Figure 3. Subgroup analysis regarding different study population; SE — standard error; CI — confidence interval.
number of patients, with a weight of 34.3% in our 
pooled result. It had the greatest influence on our 
findings. Therefore, our meta-analysis was subject 
to that study’s inherent limitations.
Conclusions
In conclusion, CKD was associated with higher 
AF recurrence rate after single catheter ablation. 
Given that the CKD prevalence is rapidly increa-
sing, there is an imperative need for better risk 
stratification of catheter ablation candidates.
Conflicts of interest: none declared
References
 1. Takahashi Y, Takahashi A, Kuwahara T et al. Renal function after 
catheter ablation of atrial fibrillation. Circulation, 2011; 124: 
2380–2387.
 2. Bohnen M, Stevenson WG, Tedrow UB et al. Incidence and 
predictors of major complications from contemporary catheter 
ablation to treat cardiac arrhythmias. Heart Rhythm, 2011; 8: 
1661–1666.
 3. Kocheril AG. Arrhythmia issues in patients with renal disease. 
Semin Nephrol, 2001; 21: 57–65.
 4. Naruse Y, Tada H, Sekiguchi Y et al. Concomitant chronic kidney 
disease increases the recurrence of atrial fibrillation after cathe-
ter ablation of atrial fibrillation: A mid-term follow-up. Heart 
Rhythm, 2011; 8: 335–341.
 5. Chao TF, Lin YJ, Chang SL et al. Associations between renal 
function, atrial substrate properties and outcome of catheter ab-
lation in patients with paroxysmal atrial fibrillation. Circ J, 2011; 
75: 2326–2332.
 6. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of obser-
vational studies in epidemiology: a proposal for reporting. Meta-
-analysis Of Observational Studies in Epidemiology (MOOSE) 
group. JAMA, 2000; 283: 2008–2012.
 7. Harris RP, Helfand M, Woolf SH et al. Current methods of the 
US Preventive Services Task Force: a review of the process. Am 
J Prev Med, 2001; 20 (3 Suppl.): 21–35.
 8. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. 
Users’ guides to the medical literature. IV. How to use an article 
about harm. Evidence-Based Medicine Working Group. JAMA, 
1994; 271: 1615–1619.
 9. Tokuda M, Yamane T, Matsuo S et al. Relationship between renal 
function and the risk of recurrent atrial fibrillation following 
catheter ablation. Heart, 2011; 97: 137–142.
 10. Berkowitsch A, Kuniss M, Greiss H et al. Impact of impaired re-
nal function and metabolic syndrome on the recurrence of atrial 
www.cardiologyjournal.org 95
Min Li et al., Chronic kidney disease and atrial fibrillation
fibrillation after catheter ablation: a long term follow-up. Pacing 
Clin Electrophysiol, 2012; 35: 532–543.
 11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring 
inconsistency in meta-analyses. BMJ, 2003; 327: 557–560.
 12. Geidel S, Lass M, Krause K et al. Persistent atrial fibrillation 
ablation concomitant to coronary surgery. Thorac Cardiovasc 
Surg, 2011; 59: 207–212.
 13. Geidel S, Krause K, Boczor S et al. Ablation surgery in patients 
with persistent atrial fibrillation: An 8-year clinical experience. 
J Thorac Cardiovasc Surg, 2011; 141: 377–382.
 14. Attaran S, Saleh HZ, Shaw M, Ward A, Pullan M, Fabri BM. Does 
the outcome improve after radiofrequency ablation for atrial 
fibrillation in patients undergoing cardiac surgery? A propens-
ity-matched comparison. Eur J Cardiothorac Surg, 2012; 41: 
806–810.
 15. Bortone A, Boveda S, Pasquie JL et al. Sinus rhythm restoration 
by catheter ablation in patients with long-lasting atrial fibrilla-
tion and congestive heart failure: Impact of the left ventricular 
ejection fraction improvement on the implantable cardioverter 
defibrillator insertion indication. Europace, 2009; 11: 1018–1023.
 16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. 
A more accurate method to estimate glomerular filtration rate 
from serum creatinine: A new prediction equation. Modification 
of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 
130: 461–470.
 17. Szczech LA. Atrial fibrillation: The beat is faster than the ans-
wers. Kidney Int, 2012; 81: 432–433.
 18. Sandhu RK, Kurth T, Conen D, Cook NR, Ridker PM, Albert CM. 
Relation of renal function to risk for incident atrial fibrillation in 
women. Am J Cardiol, 2012; 109: 538–542.
 19. House AA, Ronco C. The burden of cardiovascular risk in chronic 
kidney disease and dialysis patients (cardiorenal syndrome 
type 4). Contrib Nephrol, 2011; 171: 50–56.
 20. Baber U, Howard VJ, Halperin JL et al. Association of chronic 
kidney disease with atrial fibrillation among adults in the United 
States: REasons for Geographic and Racial Differences in Stroke 
(REGARDS) Study. Circ Arrhythm Electrophysiol, 2011; 4: 26–32.
 21. Alonso A, Lopez FL, Matsushita K et al. Chronic kidney disease 
is associated with the incidence of atrial fibrillation: The Athero-
sclerosis Risk in Communities (ARIC) study. Circulation, 2011; 
123: 2946–2953.
 22. Klein RM, Vester EG, Brehm MU et al. Inflammation of the myo-
cardium as an arrhythmia trigger. Z Kardiol, 2000; 89 (Suppl. 3): 
24–35.
 23. Voroneanu L, Covic A. Arrhythmias in hemodialysis patients. 
J Nephrol, 2009; 22: 716–725.
 24. Liu T, Li GP, Li LJ, Korantzopoulos P. Association between C-reacti-
ve protein and recurrence of atrial fibrillation after successful cardio-
version: A meta-analysis. J Am Coll Cardiol, 2007; 49: 1642–1648.
 25 Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G. Meta-ana-
lysis of association between C-reactive protein and immediate 
success of electrical cardioversion in persistent atrial fibrillation. 
Am J Cardiol, 2008; 101: 1749–1752.
 26. Dounousi E, Papavasiliou E, Makedou A et al. Oxidative stress 
is progressively enhanced with advancing stages of CKD. Am 
J Kidney Dis, 2006; 48: 752–760.
 27. Fukunaga N, Takahashi N, Hagiwara S et al. Establishment of 
a model of atrial fibrillation associated with chronic kidney 
disease in rats and the role of oxidative stress. Heart Rhythm, 
2012; 9: 2023–2031.
